Update shared on 18 Nov 2025
Analysts have maintained Archrock's fair value estimate at $31.56. Their largely unchanged forecast reflects stability in expected revenue growth and profitability metrics.
What's in the News
- Archrock announced an increase to its equity buyback plan, expanding authorization by an additional $100 million and extending the plan's duration through December 31, 2026 (Key Developments).
- The company completed the repurchase of 3,942,161 shares, representing 2.35% of shares outstanding, for a total cost of $79.7 million under the current buyback program (Key Developments).
- Archrock raised its full-year 2025 earnings guidance, now expecting net income between $265.2 million and $280.2 million (Key Developments).
Valuation Changes
- The Fair Value Estimate remained unchanged at $31.56 per share.
- The Discount Rate decreased modestly, from 8.61% to 8.07%.
- The Revenue Growth forecast fell slightly, moving from 7.18% to 7.13%.
- The Net Profit Margin is projected to rise marginally, increasing from 21.51% to 21.54%.
- The Future P/E Ratio estimate declined a bit, from 18.56x to 18.28x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.